Loading clinical trials...
Loading clinical trials...
This is a single-site, open-label, randomized pilot feasibility study conducted at The Ottawa Hospital Cancer Centre. A total of 10 participants will be randomized 1:1 to either the experimental or co...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Ottawa Hospital Research Institute
NCT01453660 · Germ Cell Cancer
NCT07401316 · Germ Cell Cancer Metastatic
NCT02433197 · Testicular Germ Cell Cancer
NCT02303015 · Germ Cell Cancer
NCT04402593 · Relapsed Germ Cell Cancer, Cisplatin Induced Tinnitus
Ottawa Hospital Cancer Centre
Ottawa, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions